Quantifying Policy Options for Reducing Future Coronary Heart Disease Mortality in England: A Modelling Study

被引:12
|
作者
Scholes, Shaun [1 ]
Bajekal, Madhavi [1 ]
Norman, Paul [2 ]
O'Flaherty, Martin [3 ]
Hawkins, Nathaniel [4 ]
Kivimaeki, Mika [5 ]
Capewell, Simon [3 ]
Raine, Rosalind [1 ]
机构
[1] UCL, Dept Appl Hlth Res, London, England
[2] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England
[3] Univ Liverpool, Liverpool Heart & Chest Hosp, Inst Cardiovasc Med & Sci, Liverpool L69 3BX, Merseyside, England
[4] Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England
[5] UCL, Dept Epidemiol & Publ Hlth, London, England
来源
PLOS ONE | 2013年 / 8卷 / 07期
基金
英国经济与社会研究理事会; 美国国家卫生研究院; 英国医学研究理事会;
关键词
CARDIOVASCULAR RISK-FACTORS; SOCIOECONOMIC INEQUALITIES; VASCULAR MORTALITY; INDIVIDUAL DATA; BLOOD-PRESSURE; TRENDS; ADULTS; ASSOCIATIONS; METAANALYSIS; PREVALENCE;
D O I
10.1371/journal.pone.0069935
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Aims: To estimate the number of coronary heart disease (CHD) deaths potentially preventable in England in 2020 comparing four risk factor change scenarios. Methods and Results: Using 2007 as baseline, the IMPACT(SEC) model was extended to estimate the potential number of CHD deaths preventable in England in 2020 by age, gender and Index of Multiple Deprivation 2007 quintiles given four risk factor change scenarios: (a) assuming recent trends will continue; (b) assuming optimal but feasible levels already achieved elsewhere; (c) an intermediate point, halfway between current and optimal levels; and (d) assuming plateauing or worsening levels, the worst case scenario. These four scenarios were compared to the baseline scenario with both risk factors and CHD mortality rates remaining at 2007 levels. This would result in approximately 97,000 CHD deaths in 2020. Assuming recent trends will continue would avert approximately 22,640 deaths (95% uncertainty interval: 20,390-24,980). There would be some 39,720 (37,120-41,900) fewer deaths in 2020 with optimal risk factor levels and 22,330 fewer (19,850-24,300) in the intermediate scenario. In the worst case scenario, 16,170 additional deaths (13,880-18,420) would occur. If optimal risk factor levels were achieved, the gap in CHD rates between the most and least deprived areas would halve with falls in systolic blood pressure, physical inactivity and total cholesterol providing the largest contributions to mortality gains. Conclusions: CHD mortality reductions of up to 45%, accompanied by significant reductions in area deprivation mortality disparities, would be possible by implementing optimal preventive policies.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Quantifying the dose-response of walking in reducing coronary heart disease risk: meta-analysis
    Henry Zheng
    Nicola Orsini
    Janaki Amin
    Alicja Wolk
    Van Thi Thuy Nguyen
    Fred Ehrlich
    European Journal of Epidemiology, 2009, 24 : 181 - 192
  • [22] Ambient temperature and coronary heart disease mortality in Beijing, China: a time series study
    Tian, Zhaoxing
    Li, Shanshan
    Zhang, Jinliang
    Jaakkola, Jouni J. K.
    Guo, Yuming
    ENVIRONMENTAL HEALTH, 2012, 11
  • [23] Prospective study of metabolic syndrome as a mortality marker in chronic coronary heart disease patients
    Mayer, Otto, Jr.
    Bruthans, Jan
    Seidlerova, Jitka
    Karnosova, Petra
    Vanek, Jiri
    Hronova, Marketa
    Gelzinsky, Julius
    Cvicela, Martina
    Wohlfahrt, Peter
    Cifkova, Renata
    Filipovsky, Jan
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2018, 47 : 55 - 61
  • [24] Decline in coronary heart disease mortality
    O'Flaherty, Martin
    MEDICINA-BUENOS AIRES, 2009, 69 (02) : 198 - 200
  • [25] The future of coronary heart disease prevention
    Wald, David S.
    CLINICAL MEDICINE, 2007, 7 (04) : 392 - 396
  • [26] The contribution of primary prevention medication and dietary change in coronary mortality reduction in England between 2000 and 2007: a modelling study
    Guzman-Castillo, M.
    Ahmed, R.
    Hawkins, N.
    Scholes, S.
    Wilkinson, E.
    Lucy, J.
    Capewell, S.
    O'Flaherty, M.
    BMJ OPEN, 2015, 5 (01):
  • [27] Cost-Effectiveness of Treatments Reducing Coronary Heart Disease Mortality in Ireland, 2000 to 2010
    Bennett, Kathleen
    Kabir, Zubair
    Barry, Michael
    Tilson, Lesley
    Fidan, Dogan
    Shelley, Emer
    Capewell, Simon
    VALUE IN HEALTH, 2009, 12 (01) : 10 - 15
  • [28] Coronary heart disease and mortality following a breast cancer diagnosis
    Guo, Aixia
    Zhang, Kathleen W.
    Reynolds, Kristi
    Foraker, Randi E.
    BMC MEDICAL INFORMATICS AND DECISION MAKING, 2020, 20 (01)
  • [29] Variation in secondary prevention of coronary heart disease: the INTERASPIRE study
    McEvoy, John William
    Jennings, Catriona
    Kotseva, Kornelia
    De Bacquer, Dirk
    De Backer, Guy
    Erlund, Iris
    Vihervaara, Terhi
    Lip, Gregory Y. H.
    Ray, Kausik K.
    Ryden, Lars
    Abreu, Ana
    Almahmeed, Wael
    Ambari, Ade Meidian
    Ge, Junbo
    Hasan-Ali, Hosam
    Huo, Yong
    Jankowski, Piotr
    Jimenez, Rodney M.
    Li, Yong
    Mahmood Zuhdi, Ahmad Syadi
    Makubi, Abel
    Mbakwem, Amam Chinyere
    Mbau, Lilian
    Estrada, Jose Luis Navarro
    Ogah, Okechukwu Samuel
    Ogola, Elijah Nyainda
    Quintero-Baiz, Adalberto
    Sani, Mahmoud Umar
    Liprandi, Maria Ines Sosa
    Tan, Jack Wei Chieh
    Triana, Miguel Alberto Urina
    Yeo, Tee Joo
    Ganly, Sandra
    Adamska, Agnieszka
    Wood, David
    EUROPEAN HEART JOURNAL, 2024, 45 (39) : 4184 - 4196
  • [30] Fall in population-based mortality from coronary heart disease negated in people with diabetes mellitus: data from England
    Ecclestone, T. C.
    Yeates, D. G. R.
    Goldacre, M. J.
    DIABETIC MEDICINE, 2015, 32 (10) : 1329 - 1334